Organisation paid for research Program year 2023 Source: CMS Open Payments

Chear Ctr LLC

Neither a doctor nor a teaching hospital

Research payments

$36,970

12 payments

Through program year 2023, Chear Ctr LLC is reported as receiving $36,970 in research payments, across 12 payments.

By program year

4 rows
Year Kind Amount Payments
2023 Research $21,787 6
2022 Research $9,111 2
2021 Research $238 1
2020 Research $5,834 3

Breakdown

Who paid Research payments · program years 2020–2023
  1. Janssen Pharmaceuticals, Inc $30,898 8 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $6,072 4 payments
Studies the money was for Research payments · program years 2020–2023
  1. A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older $30,898 8 payments
  2. Tio & Olo versus PBO stratified by PIFR $6,072 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record